PCN87 COST-EFFECTIVNESS ANALYSIS OF DABRAFENIB PLUS TRAMETINIB AS ADJUVANT TREATMENT FOR BRAF V600 MUTATION-POSITIVE MELANOMA AFTER SURGICAL RESECTION IN CANADA- A SOCIETAL PERSPECTIVE
Abstract
Authors
D. Stellato M. Thabane C. Beauchemin R. Bornheimer J.N. Charron J. Lachaine K. Mathurin T.E. Delea